Progress in Breast Cancer: Overview

被引：9
作者：
Arteaga, Carlos L. [1 ,2 ,3 ]
机构：
[1] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Breast Canc Res Program, Nashville, TN 37232 USA
来源：
CLINICAL CANCER RESEARCH | 2013年 / 19卷 / 23期
关键词：
ENDOCRINE-THERAPY; NEOADJUVANT THERAPY; TRASTUZUMAB; METASTASIS; PERTUZUMAB; EXPRESSION; APPROVAL; MODELS; SAFETY; LONG;
D O I：
10.1158/1078-0432.CCR-13-2549
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This edition of CCR Focus titled Research in Breast Cancer: Frontiers in Genomics, Biology, and Clinical Investigation reviews six topics that cover areas of translational research of high impact in breast cancer. These topics represent areas of breast cancer research where significant progress has occurred but also where very important challenges remain. The papers in this CCR Focus section are contributed by experts in the respective areas of investigation. Herein, key aspects of these contributions and the research directions they propose are reviewed. (C)2013 AACR.
引用
收藏
页码：6353 / 6359
页数：7
相关论文
共 32 条
[1]  
Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0
[2]   Models, mechanisms and clinical evidence for cancer dormancy [J].
Aguirre-Ghiso, Julio A. .
NATURE REVIEWS CANCER, 2007, 7 (11) :834-846
[3]   High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates [J].
Alexe, Gabricla ;
Dalgin, Gul S. ;
Scanfeld, Daniel ;
Tamayo, Pablo ;
Mesirov, Jill P. ;
DeLisi, Charles ;
Harris, Lyndsay ;
Barnard, Nicola ;
Martel, Maritza ;
Levine, Arnold J. ;
Ganesan, Shridar ;
Bhanot, Gyan .
CANCER RESEARCH, 2007, 67 (22) :10669-10676
[4]   The genomic map of breast cancer: which roads lead to better targeted therapies? [J].
Balko, Justin M. ;
Stricker, Thomas P. ;
Arteaga, Carlos L. .
BREAST CANCER RESEARCH, 2013, 15 (04)
[5]   Neoadjuvant Therapy as a Platform for Drug Development and Approval in Breast Cancer [J].
Bardia, Aditya ;
Baselga, Jose .
CLINICAL CANCER RESEARCH, 2013, 19 (23) :6360-6370
[6]   Deep Time: The Long and the Short of Adjuvant Endocrine Therapy for Breast Cancer [J].
Burstein, Harold J. ;
Griggs, Jennifer J. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (07) :684-686
[7]   Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients [J].
Byrski, T. ;
Huzarski, T. ;
Dent, R. ;
Gronwald, J. ;
Zuziak, D. ;
Cybulski, C. ;
Kladny, J. ;
Gorski, B. ;
Lubinski, J. ;
Narod, S. A. .
BREAST CANCER RESEARCH AND TREATMENT, 2009, 115 (02) :359-363
[8]   Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer [J].
Denkert, Carsten ;
Loibl, Sibylle ;
Noske, Aurelia ;
Roller, Marc ;
Mueller, Berit Maria ;
Komor, Martina ;
Budczies, Jan ;
Darb-Esfahani, Silvia ;
Kronenwett, Ralf ;
Hanusch, Claus ;
von Toerne, Christian ;
Weichert, Wilko ;
Engels, Knut ;
Solbach, Christine ;
Schrader, Iris ;
Dietel, Manfred ;
von Minckwitz, Gunter .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) :105-113
[9]   Can Immunity to Breast Cancer Eliminate Residual Micrometastases? [J].
Disis, Mary L. ;
Stanton, Sasha E. .
CLINICAL CANCER RESEARCH, 2013, 19 (23) :6398-6403
[10]   Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer [J].
Dowsett, Mitch ;
Smith, Ian E. ;
Ebbs, Stephen R. ;
Dixon, J. Michael ;
Skene, Anthony ;
A'Hern, Roger ;
Salter, Janine ;
Detre, Simone ;
Hills, Margaret ;
Walsh, Geraldine .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (02) :167-170
1234